20
Kyongbo Pharmaceutical Co., Ltd. Asan-si Kr, based in South Korea, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Raloxifene hydrochloride, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2015-174 - Rev 00
This Chemical Type CEP, issued on November 02, 2016, remains in force until July 12, 2021, ensuring its reliability within the pharmaceutical industry.
Substance Number 2375 associated with this CEP further emphasizes